v3.26.1
Organization (Details) - USD ($)
12 Months Ended
Aug. 28, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Organization [Line Items]          
Increase of PIPE financing (in Dollars)   $ 13,200,000 $ 7,545,772  
Ordinary shares, outstanding [1]   70,789,261 64,730,411    
Warrant [Member]          
Organization [Line Items]          
Warrant outstanding 16,925,000 16,925,000  
YD Biopharma [Member]          
Organization [Line Items]          
Percentage of business combination 100.00%        
Business combination outstanding shares 4,140,948 4,140,948      
Transaction value (in Dollars) $ 647,304,110        
Share price (in Dollars per share) $ 10        
YD Biopharma [Member] | Warrant [Member]          
Organization [Line Items]          
Warrant outstanding 16,925,000        
PIPE Financing [Member]          
Organization [Line Items]          
Share issue 1,650,000        
Increase of PIPE financing (in Dollars) $ 13,200,000        
Shares issue price per share (in Dollars per share) $ 8        
Ordinary Shares [Member]          
Organization [Line Items]          
Ordinary shares, outstanding 70,521,359 70,789,261 64,730,411 64,730,411 64,730,411
Ordinary Shares [Member] | YD Biopharma [Member]          
Organization [Line Items]          
Business combination outstanding shares 64,730,411        
[1] Shares related information and additional paid-in capital are retrospectively restated for effect of recapitalization completed on August 28, 2025.